A novel role for the fifth component of complement (C5) in cardiac physiology.
We have previously demonstrated that C5-deficient A/J and recombinant congenic BcA17 mice suffer from cardiac dysfunction when infected with C. albicans blastospores intravenously. During these studies we had observed that, even in the control un-infected state, BcA17 hearts displayed alterations in...
Main Authors: | Alaka Mullick, Jessy Tremblay, Zully Leon, Philippe Gros |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21829669/pdf/?tool=EBI |
Similar Items
-
Genetic control of susceptibility to infection with Candida albicans in mice.
by: Irena Radovanovic, et al.
Published: (2011-04-01) -
Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5.
by: Adrianna Latuszek, et al.
Published: (2020-01-01) -
Structure of and influence of a tick complement inhibitor on human complement component 5.
by: Fredslund, F, et al.
Published: (2008) -
Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity
by: D. V. A. Khoa, et al.
Published: (2015-09-01) -
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.
by: Paolo Durigutto, et al.
Published: (2013-01-01)